Purpose Genetic and genomic testing can provide valuable information on individuals' risk
of chronic diseases, presenting an opportunity for risk-tailored disease screening to improve …

An increasing number of economic evaluations are published annually investigating the
economic effectiveness of pharmacogenomic (PGx) testing. This work was designed to …

Health economic evidence is needed to inform the design of high-value and cost-effective
processes for returning genomic results from analyses for additional findings (AF). This study …

Objective To investigate the preferences of persons with a history of stroke for various
attributes of rehabilitation using a discrete choice experiment (DCE). Design Cross-sectional …

Aim: To elicit preferences for pharmacogenomic (PGx) testing in polypharmacy patients.
Materials & methods: A face-to-face discrete choice experiment survey was designed and …

Objectives The aim of this study was to elicit the willingness-to-pay (WTP) for genomic
testing, using contingent valuation, among people with lived experience of genetic …

Purpose Although preconception reproductive genetic carrier screening (RGCS) is preferred
to screening during pregnancy, population-wide preconception screening is not routinely …

Given that pediatric genomic sequencing (GS) may have implications for the health and well-
being of both the child and family, a clearer understanding of the key drivers of the utility of …

Objective: The objective was to investigate the association of clinical attributes with decision
making for performing appendectomy and making preoperative preparations for …

Background Understanding service user preferences is key to effective health care decision
making and efficient resource allocation. It is of particular importance in the management of …